IOM’s William Vodra Stands His Ground
This article was originally published in The Gray Sheet
Executive SummaryResponding to widespread criticism of the Institute of Medicine’s controversial 510(k) reform report, committee member William Vodra likens it to the old fairy tale of “the emperor’s new clothes.”
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.